MIRAVANT MEDICAL TECHNOLOGIES
10-Q, EX-27.1, 2000-11-14
PHARMACEUTICAL PREPARATIONS
Previous: MIRAVANT MEDICAL TECHNOLOGIES, 10-Q, 2000-11-14
Next: VERSATECH INC, 10QSB, 2000-11-14



<TABLE> <S> <C>

<ARTICLE>                     5
<LEGEND>
THIS  SCHEDULE  CONTAINS  SUMMARY  FINANCIAL   INFORMATION  EXTRACTED  FROM  THE
CONSOLIDATED  BALANCE SHEETS AND CONSOLIDATED  STATEMENTS OF OPERATIONS FOUND IN
THE  COMPANY'S  FORM  10-Q FOR THE  PERIOD  ENDED  SEPTEMBER  30,  2000,  AND IS
QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>

<MULTIPLIER>                                   1,000

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                              Dec-31-2000
<PERIOD-START>                                 Jan-1-2000
<PERIOD-END>                                   Sep-30-2000
<CASH>                                          1,586
<SECURITIES>                                   20,900
<RECEIVABLES>                                   2,381
<ALLOWANCES>                                        0
<INVENTORY>                                         0
<CURRENT-ASSETS>                               25,854
<PP&E>                                         12,098
<DEPRECIATION>                                 (9,418)
<TOTAL-ASSETS>                                 32,120
<CURRENT-LIABILITIES>                           4,045
<BONDS>                                             0
                               0
                                         0
<COMMON>                                      157,034
<OTHER-SE>                                   (153,285)
<TOTAL-LIABILITY-AND-EQUITY>                   32,120
<SALES>                                             0
<TOTAL-REVENUES>                                3,763
<CGS>                                               0
<TOTAL-COSTS>                                  20,050
<OTHER-EXPENSES>                                    0
<LOSS-PROVISION>                                    0
<INTEREST-EXPENSE>                              1,557
<INCOME-PRETAX>                               (16,832)
<INCOME-TAX>                                        0
<INCOME-CONTINUING>                           (16,832)
<DISCONTINUED>                                      0
<EXTRAORDINARY>                                     0
<CHANGES>                                           0
<NET-INCOME>                                  (16,832)
<EPS-BASIC>                                     (0.92)
<EPS-DILUTED>                                   (0.92)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission